Renaissance Technologies (RenTech)'s WVE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 236,420 shares of Wave Life Sciences Ltd. (WVE) worth $4.02 M, representing 0.01% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in WVE, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 236,420 shares. Largest reduction occurred in Q1 2021, reducing 235,620 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Wave Life Sciences (WVE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Wave Life Sciences (WVE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +236,420 | New Buy | 236,420 | $17.00 |
| Q2 2025 | -210,220 | Sold Out | 0 | $0.00 |
| Q1 2025 | +168,700 | Add 406.31% | 210,220 | $8.08 |
| Q4 2024 | -63,000 | Reduce 60.28% | 41,520 | $12.37 |
| Q3 2024 | +104,520 | New Buy | 104,520 | $8.20 |
| Q2 2024 | -164,620 | Sold Out | 0 | $0.00 |
| Q1 2024 | +149,920 | Add 1019.86% | 164,620 | $6.17 |
| Q4 2023 | -17,000 | Reduce 53.63% | 14,700 | $5.03 |
| Q3 2023 | -133,120 | Reduce 80.77% | 31,700 | $5.74 |
| Q2 2023 | +133,020 | Add 418.30% | 164,820 | $0.00 |
| Q1 2023 | -62,700 | Reduce 66.35% | 31,800 | $0.01 |
| Q4 2022 | -43,400 | Reduce 31.47% | 94,500 | $0.01 |
| Q3 2022 | -25,700 | Reduce 15.71% | 137,900 | $3.61 |
| Q2 2022 | -41,594 | Reduce 20.27% | 163,600 | $3.25 |
| Q1 2022 | +167,894 | Add 450.12% | 205,194 | $2.00 |
| Q4 2021 | +37,300 | New Buy | 37,300 | $3.14 |
| Q3 2021 | -87,120 | Sold Out | 0 | $0.00 |
| Q2 2021 | +87,120 | New Buy | 87,120 | $6.66 |
| Q1 2021 | -235,620 | Sold Out | 0 | $0.00 |
| Q4 2020 | +235,620 | New Buy | 235,620 | $7.87 |
| Q3 2019 | -19,100 | Sold Out | 0 | $0.00 |
| Q2 2019 | +10,854 | Add 131.63% | 19,100 | $26.07 |
| Q1 2019 | +8,246 | New Buy | 8,246 | $38.81 |
| Q1 2017 | -15,400 | Sold Out | 0 | $0.00 |
| Q4 2016 | +15,400 | New Buy | 15,400 | $26.17 |
| Q3 2016 | -35,700 | Sold Out | 0 | $0.00 |
| Q2 2016 | +35,700 | New Buy | 35,700 | $20.70 |
Renaissance Technologies (RenTech)'s Wave Life Sciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Wave Life Sciences Ltd. (WVE) in Q2 2016, acquiring 35,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Wave Life Sciences Ltd. (WVE) for 27 quarters since Q2 2016.
Renaissance Technologies (RenTech)'s largest addition to Wave Life Sciences Ltd. (WVE) was in Q4 2025, adding 236,420 shares worth $4.02 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 236,420 shares of Wave Life Sciences Ltd. (WVE), valued at approximately $4.02 M.
As of the Q4 2025 filing, Wave Life Sciences Ltd. (WVE) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Wave Life Sciences Ltd. (WVE) was 236,420 shares, as reported at the end of Q4 2025.